Clinical Validation Study for iVue

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01242553

Enrollment

Registered

2010-11-17

Start date

2009-10-31

Completion date

2010-09-30

Last updated

2017-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal and Ocular Pathology

Brief summary

To demonstrate clinical substantial equivalence of iVue as comparable to commercially available RTVue.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Normal: Normal results from clinical exam and free of ocular pathology. * Glaucoma: Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma. * Cornea: Clinical exam results consistent with cornea pathology. * Retina: Clinical exam results consistent with retina pathology

Design outcomes

Primary

Measure	Time frame
thickness of ocular structures	—

Countries

United States

Outcome results